Two board members of Woodford Patient Capital Trust work at firms held in the portfolio, The Times has reported, raising questions about its independence.
Susan Searle, chair of the board, is deputy chair of Mercia Technologies and a non-executive director at Benchmark Holdings, according to The Times. As at 31 March, Mercia represents 0.8% of the portfolio while Benchmark's weighting stands at 0.46%. Meanwhile, director Scott Brown is also chief executive of Nexeon Limited, which represents 0.41% of the trust. While investment trust boards do not manage or determine any stock choices, there is potential for a conflcit of interest as they are responsible for overseeing investment policies and strategies. A spokesperson at Woodford...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes